Skip to content
Storytelling Co – Lifestyle
Author:
Memo Therapeutics AG
Memo Therapeutics AG Presents Further Analyses of the Phase II Trial Results of Potravitug for the Treatment of BKPyV Infection in Kidney Transplant Recipients in an Oral Presentation at the 63rd European Renal Association Congress
June 5, 2026